ANZCTR - Registration

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers

Trial registered on ANZCTR

Registration number

ACTRN12611000929909

Ethics application status

Approved

Date submitted

23/08/2011

Date registered

30/08/2011

Date last updated

4/12/2015

Type of registration

Retrospectively registered

Titles & IDs

Public title

A Randomized Controlled Trial (RCT) of Internet-based Treatment of Anxiety Symptoms in Older Adults

Scientific title

A randomised controlled trial of Internet based treatment for older adults comparing Immediate treatment vs. delayed treatment on symptoms of anxiety.

Secondary ID [1]

Nil

Universal Trial Number (UTN)

Trial acronym

Linked study record

Health condition

Health condition(s) or problem(s) studied:

Anxiety

Condition category

Condition code

Mental Health

Anxiety

Intervention/exposure

Study type

Interventional

Description of intervention(s) / exposure

Participants will be randomly assigned to one of two groups: 1)an immediate treatment group, or; 2) a delayed waitlist control group (beginning 9 weeks after the immediate treatment group begin. Participants will receive access to an 8 week internet-based treatment program.All participants will have at least mild symptoms of anxiety (GAD-7 total score >7). All participants will complete 5 lessons of Internet based treatment about management of symptoms of anxiety and stress. One lesson will be completed every 7 to 10 days. Each lesson will take about 15 minutes to complete. Participants will also have access to summaries of each lesson, and will read anonymous stories about other people with anxiety, taking a further 20 minutes per week. All participants will also receive automatic emails and brief weekly (<10minutes week) supportive telephone calls from a clinical psychologist.

Study questionnaires will be administered at application, pre-treatment, post-treatment, at 3-months post-treatment. These will take about 20-30 minutes to complete. The treatment materials are based on the Wellbeing Program, which teaches evidence-based cognitive behavioural skills.

Intervention code [1]

Treatment: Other

Intervention code [2]

Behaviour

Comparator / control treatment

The delayed waitlist control goup (beginning the course 9 weeks after the immediate treatment group beings). This is a wait-list control group.

Control group

Active

Outcomes

Primary outcome [1]

Anxiety is measured by the Generalised Anxiety Disorder 7 Item Scale (GAD-7).

Timepoint [1]

Administered at pre-treatment, prior to each Lesson in the course, post-treatment, and at 3-months post-treatment

Primary outcome [2]

Symptoms and severity of depression is measured by the Patient Health Questionnaire-9 (PHQ-9)

Timepoint [2]

Administered at pre-treatment, prior to each Lesson in the course, post-treatment, and at 3-months post-treatment

Primary outcome [3]

Symptoms and severity of depression is measured by the Geriatric Depression Scale (GDS)

Timepoint [3]

Administered at pre-treatment, prior to each Lesson in the course, post-treatment, and at 3-months post-treatment

Secondary outcome [1]

Depression, Anxiety and Stress is measured by the Depression, Anxiety, Stress Scale (21 item) (DASS-21).

Timepoint [1]

Administered at pre-treatment, post-treatment, and at 3-months post-treatment.

Secondary outcome [2]

Health status is measured by the European Quality of Life-5 Dimensions: 5 level version (EQ-5D-5L).

Timepoint [2]

Administered at pre-treatment, post-treatment, and at 3-months post-treatment.

Secondary outcome [3]

Health service use (Number of visits to different health professionals, impact of anxiety and depression on absenteeism and reduced productivity, and impact on any caregivers) is measured by the Service Use Quesionnaire (based on the Adult Service Use Schedule (AD-SUS, Byford et al., 2010)).

Timepoint [3]

Administered at pre-treatment, post-treatment, and at 3-months post-treatment.

Secondary outcome [4]

Neuroticism is measured by using the NEO-Five Factor Inventory (NEO-FFI) Neuroticism scale.

Timepoint [4]

Administered at pre-treatment, post-treatment, and at 3-months post-treatment

Secondary outcome [5]

Perception of cognitive health is measured by the Cognitive Failures Questionnaire (CFQ).

Timepoint [5]

Administered at pre-treatment, post-treatment, and at 3-months post-treatment

Secondary outcome [6]

Positive and adaptive behaviours are measured by the Things You Do Questionnaire (TYDQ)

Timepoint [6]

Administered at pre-treatment, post-treatment, and at 3-months post-treatment

Eligibility

Key inclusion criteria

1. Resident of Australia
2. 60 years – 75 years of age
3. Have access to a computer, the Internet, and use of a printer
4. Not currently participating in CBT
5. Not using illicit drugs or consuming more than three standard drinks/day
6. Not currently experiencing a psychotic mental illness or severe symptoms of depression (defined as a total score >19 or responding >2 to Question 9 [suicidal ideation] on the PHQ-9)
7. Reports that they have been assessed by a GP or specialist to rule out a physical cause for their anxiety
8. A total score >7 on the GAD-7 (indicating at least mild symptoms of anxiety). Note that meeting diagnostic criteria for a formal anxiety disorder is NOT an inclusion criteria – instead, participants need to have elevated symptoms of anxiety as measured by the GAD-7
9. If taking medication for anxiety or depression, been taking the same dose for at least 1 month and not intend to change that dose during the course of the program
10. Prepared to provide name, phone number and address, and to provide the name and address of a local general practitioner
11. Prepared to provide informed consent

Minimum age

60 Years

Maximum age

75 Years

Sex

Both males and females

Can healthy volunteers participate?

Key exclusion criteria

1. Severe depression (score of 20 or greater on PHQ-9)
2. Suicidal intent or plan
3. Scoring below cut-off on the GAD-7
4. Current substance abuse
5. Psychosis
6. Presenting problem not anxiety

Study design

Purpose of the study

Treatment

Allocation to intervention

Randomised controlled trial

Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)

Participants apply online, and those who meet inclusion criteria are administered a telephone interview to identify psychiatric diagnoses using the Mini Neuropsychiatric Interview Schedule (MINI 5.0.0). Participants are then randomly allocated to one of the two groups. Allocation concealment will occur by providing allocation details for each successive participant in a sealed envelope, which recruitment staff are required to open serially.

Methods used to generate the sequence in which subjects will be randomised (sequence generation)

Participants will be randomized using a list generated prior to the study via a software program (www.random.org), at another site, in another country. The list will then be transcribed and details transferred to sealed envelopes.

Masking / blinding

Open (masking not used)

Who is / are masked / blinded?

Intervention assignment

Parallel

Other design features

Phase

Not Applicable

Type of endpoint/s

Efficacy

Statistical methods / analysis

Recruitment

Recruitment status

Completed

Date of first participant enrolment

Anticipated

23/08/2011

Actual

24/08/2011

Date of last participant enrolment

Anticipated

Actual

25/04/2012

Date of last data collection

Anticipated

Actual

Sample size

Target

102

Accrual to date

Final

Recruitment in Australia

Recruitment state(s)

Funding & Sponsors

Funding source category [1]

Charities/Societies/Foundations

Name [1]

beyondblue

Address [1]

PO Box 6100
Hawthorn West
VIC3122

Country [1]

Australia

Primary sponsor type

University

Name

Macquarie University

Address

Balaclava Road, North Ryde,
Macquarie University NSW 2109

Country

Australia

Secondary sponsor category [1]

None

Name [1]

Address [1]

Country [1]

Ethics approval

Ethics application status

Approved

Ethics committee name [1]

Macquarie University Human Research Ethics Committee

Ethics committee address [1]

E11A, Macquarie University NSW 2109

Ethics committee country [1]

Australia

Date submitted for ethics approval [1]

10/05/2011

Approval date [1]

15/07/2011

Ethics approval number [1]

5201100470

Summary

Brief summary

The purpose of this project is to explore whether a clinician-guided treatment program can help to reduce anxiety symptoms in a population of mature adults (aged 60-75), when administered over the internet. A secondary purpose is to determine how acceptable people find this form of treatment. The study will inform how services can best improve future treatment programs for mature adults with anxiety.

Trial website

www.ecentreclinic.org

Trial related presentations / publications

1. Gun, S.Y., Titov, N., Andrews G. (2011). Acceptability of Internet treatment of anxiety and depression. Australasian Psychiatry, 19(3), 259-264. 
2. Titov, N. (2011). Internet-delivered psychotherapy for depression in adults. Current Opinion in Psychiatry, 24, 18-23. 
3. Andrews, G., Cuijpers, P., Craske, M., McEvoy, P., & Titov, N. (2010). Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: A meta-analysis. PLoS ONE, 5: e13196. 
4. Andrews, G., & Titov, N. (2010). Is Internet treatment ready for prime time? Medical Journal of Australia, 192, S45-S47. 
5. Titov, N., Sachdev, P., & Andrews, G. (2010). Computer-delivered cognitive behavioural therapy (CCBT) – Effective and getting ready for dissemination. F1000 Medicine Reports, 2, 49. 
6. Titov, N., Andrews, G., Kemp, A., & Robinson, E. (2010). Characteristics of adults with anxiety or depression treated at an Internet clinic: Comparison with a national survey and an outpatient clinic. PLoS ONE, 5. 
7. Andrews, G., & Titov, N. (2009). Hit and Miss: Innovation and dissemination of evidence based psychological treatments. Behaviour Research and Therapy, 47, 974-979. 
8. Titov, N. (2007). The status of computerized cognitive behavioural therapy (CCBT) for adults: A review. Australian and New Zealand Journal of Psychiatry, 41, 95-114.
9. Dear, B. F., Titov, N., Sunderland, M., McMillan, D., Anderson, T., Lorian, C. & Robinson, E. (In press). Psychometric comparison of the GAD-7 and the PSWQ for measuring response during treatment of generalised anxiety disorder. Cognitive Behaviour Therapy.
10. Robinson, E., Titov, N., Andrews, G., McIntyre, K., Schwencke, G., & Solley, K. (2010). Internet treatment for generalized anxiety disorder: A randomized controlled trial comparing clinician vs. technician assistance. PLoS ONE, 5, e10942. 
11. Titov, N., Andrews, G., Robinson, E., Schwencke, G., Johnston, L., Solley, K., & Choi, I. (2009). Clinician-assisted internet treatment is effective for generalized anxiety disorder: randomized controlled trial. Australian and New Zealand Journal of Psychiatry, 43, 905-912. 
12. Wims, E., Titov, N., Andrews, G., & Choi, I. (2010). Clinician-assisted Internet-based treatment is effective for panic: A randomized controlled trial. Australian and New Zealand Journal of Psychiatry, 44, 599 - 607. 
13. Wims, E., Titov, N., & Andrews, G. (2008). The Climate Panic program: an open trial of Internet-based treatment for panic disorder. Electronic Journal of Applied Psychology, 4. 
14. Andrews, G., Davies, M., & Titov, N. (2011). An effectiveness randomized controlled trial of face to face versus internet cognitive behaviour therapy for social phobia. Australian and New Zealand Journal of Psychiatry. 45, 337 - 340. 
15. Titov, N., Andrews, G., Schwencke, G., Robinson, E., Peters, L., & Spence, J. (2010). An RCT of Internet CBT for social phobia with and without motivational enhancement strategies. Australian and New Zealand Journal of Psychiatry, 44, 938 - 945. 
16. Titov, N., Gibson, M., Andrews, G., & McEvoy, P. (2009). Internet treatment for social phobia reduces comorbidity. Australian and New Zealand Journal of Psychiatry, 43, 754 – 759. 
17. Titov, N., Andrews, G., Schwencke, G., Solley, K., Johnston, L., & Robinson, E. (2009). An RCT comparing effect of two types of support on severity of symptoms for people completing Internet-based cognitive behaviour therapy for social phobia. Australian and New Zealand Journal of Psychiatry, 43, 920 - 926. 
18. Titov, N., Andrews, G., Choi, I., Schwencke, G., & Johnston, L. (2009). Randomized controlled trial of web-based treatment of social phobia without clinician guidance. Australian and New Zealand Journal of Psychiatry, 43, 913 - 919.
19. Titov, N., Andrews, G., Johnston, L., Schwencke, G., & Choi, I. (2009). The Shyness Program: Longer Term Benefits, Cost-Effectiveness, and Acceptability. Australian & New Zealand Journal of Psychiatry 43, 36 - 44. 
20. Aydos, L. R., Titov, N., & Andrews, G. (2009). Shyness 5: The clinical effectiveness of Internet-based clinician-assisted treatment of social phobia. Australasian Psychiatry, 17, 488 - 492. 
21. Titov, N., Andrews, G., Choi, I., Schwencke, G., & Mahoney, A. (2008). Shyness 3: An RCT of guided vs unguided internet based CBT for social phobia. Australian & New Zealand Journal of Psychiatry, 42, 1030 - 1040. 
22. Titov, N., Andrews, G., & Schwencke, G. (2008). Shyness 2: Treating social phobia online: replication and extension. Australian and New Zealand Journal of Psychiatry, 42, 595 - 605. 
23. Titov, N., Andrews, G., Schwencke, G., Drobny, J., & Einstein, D. (2008). Shyness 1: Distance treatment for social over the Internet. A randomized controlled trial. Australian & New Zealand Journal of Psychiatry, 42, 585 - 594.

Public notes

Contacts

Principal investigator

Name

Prof Nickolai Titov

Address

Centre for Emotional Health, Macquarie University, Ryde, NSW, 2019

Country

Australia

Phone

+61 2 98509901

Fax

nick.titov@mq.edu.au

Contact person for public queries

Name

Associate Professor Nickolai Titov

Address

Centre for Emotional Health, Macquarie University, Ryde, NSW, 2019

Country

Australia

Phone

+612 9850 9901

Fax

+612 9850 8062

nick.titov@mq.edu.au

Contact person for scientific queries

Name

Associate Professor Nickolai Titov

Address

Centre for Emotional Health, Macquarie University, Ryde, NSW, 2019

Country

Australia

Phone

+612 9850 9901

Fax

+612 9850 8062

nick.titov@mq.edu.au

No information has been provided regarding IPD availability

What supporting documents are/will be available?

No Supporting Document Provided

Results publications and other study-related documents

Documents added manually

No documents have been uploaded by study researchers.

Documents added automatically

Source	Title	Year of Publication	DOI
Embase	Clinical and Cost-Effectiveness of Therapist-Guided Internet-Delivered Cognitive Behavior Therapy for Older Adults With Symptoms of Anxiety: A Randomized Controlled Trial.	2015	https://dx.doi.org/10.1016/j.beth.2014.09.007

N.B. These documents automatically identified may not have been verified by the study sponsor.

Trial Review

Registering a new trial?

Documents added manually

Documents added automatically